Explained: AZD7442, the antibody combination against Covid-19 that the US is backing with $500 million | Explained News,The Indian Express

Explained: AZD7442, the antibody combination against Covid-19 that the US is backing with $500 million | Explained News,The Indian Express

Explained: AZD7442, the antibody combination against Covid-19 that the US is backing with $500 million

October 14, 2020 9:44 am

AZD7442, a similar class of the drug cocktail used to treat US President Donald Trump recently, is a combination of two long-acting monoclonal antibodies (LAAB). AstraZeneca developed it using its proprietary technology with the aim of preventing Covid-19 infection for a long duration.